Efficacy of Ganaton (itopride hydrochloride) use in the treatment of patients with functional dyspepsia
- Authors: Konanykhina SY.1, Serdyuk OA1, Stepanova II1, Kastorina ML1, Konanychina SY.1, Serduk OA1, Stepanova II1, Kastorina ML1
-
Affiliations:
- Issue: No 13 (2009)
- Pages: 55-59
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/277447
- ID: 277447
Cite item
Full Text
Abstract
About the authors
S Yu Konanykhina
O A Serdyuk
I I Stepanova
M L Kastorina
S Yu Konanychina
O A Serduk
I I Stepanova
M L Kastorina
References
- Dunn BE, Cohen Y, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997;10:720-41.
- EUROGAST Study Group. An international association between Helicobacter infection and gastric cancer. Lancet 1993;341:1359-62.
- Аруин Л.И., Григорьев П.Я., Исаков В.А. и др. Хронический гастрит. Амстердам, 1993. 370 с.
- Логинов А.С., Аруин Л.И., Ильченко А.А. Язвенная болезнь и Helicobacter pylori: новые аспекты патогенетической терапии. М., 1993. 230 с.
- Koudryavtseva L, Isakov VA, Ivanikov IO, et al. Evolution of H. pylori primary resistance to antimicrobial agents in Moscow (Russia) in 1996-1998. Gut 2000;47(Suppl. 1):A8.
- Циммерман Я.С., Зиннатуллин М.Р. Клиническая медицина. 1999. № 2. С. 52-56.
- Graham DY. Antibiotic resistance in Helicobacter pylori: implications for therapy. Gastroenterology 1998;115:1272-77.
- Hooton C, Dempsey C, Keohane J, et al. Helicobacter pylori: prevalence of antimicrobial resistance in clinical isolates. Br J Biomed Sci 2006;63:113-16.
- Нижевич А.А., Казанов Р.С., Сатаев В.У. Использование ранитидина, а также амоксициллина и фуразолидона для эрадикации Helicobacter pylori у детей. Gut 2001;49(Suppl. 11):A77.
- Щербаков П.Л., Вартапетова Е.Е., Нижевич А.А. и др. Эффективность и безопасность применения висмута трикалия дицитрата (Де-Нол) у детей // Клиническая фармакология и терапия. 2005. Т. 14. № 1. С. 41-44.
- Нижевич А.А., Щербаков П.Л., Казанов Р.Ш. и др. Эрадикация Helicobacter pylori у детей после неудачной попытки первичной терапии: преимущества четырехкомпонентной схемы лечения с использованием нифурателя и фуразолидона. Aliment Pharmacol Ther 2005;22:881-87.
- Исаков В.А., Домарева И., Кудрявцева Л.В. и др. Сравнение эффективности фуразолидонсодержащей трехкомпонентной и четырехкомпонентной схем эрадикационной терапии при наличии резистентности Helicobacter pylori к метронидазолу. Aliment Pharmacol Ther 2002;16:1277-82.
- Нижевич А.А., Сатаев В.У., Ахмадеева А.Г. и др. Тройная нифурателсодержащая антихеликобактерная терапия 1-й линии у детей. Helicobacter 2007;12:132-35.
- Wong WM, Wong BCY, Lu H, et al. One-week omeprasole, furasolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies. Aliment Pharmacol Ther 2002;16:793-98.
- Liu W-Z, Xiao S-D, Shi Y, et al. Furasolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1999;13:317-22.
- Fakheri H, Merat S, Hosseini V, et al. Low-dose furasolidone in triple and quadruple regimens of Helicobacter pylori eradication. Aliment Pharmacol Ther 2004;19:89-93.
- Elilsur Y, Ruessmann H, Lawrence Z, et al. Clarithromycin resistance in Helicobacter pylori- infected children - West Virginia experience. Helicobacter 2003;8:459.
- Kindermann A, Demmelmair H, Koletzko B, et al. Influence of age on 13C-urea breath test results in children. J Pediatr Gastroenterol Nutr 2000;30:85-91.
- Imrie C, Rowland M, Bourke B, et al. Limitations to carbon 13-labeled urea breath testing for Helicobacter pylori in infants. J Pediatr 2001;139:734-37.
- Khanna B, Cutler A, Israel NR, et al. Use caution with serologic testing for Helicobacter pylori infection in children. J Infect Dis 1998;178:460-65.
- Kindermann A, Konstantopoulos N, Lehn N, et al. Evalution of two commercial enzyme immunoassays, testing immunoglobulin G (IgG) and IgA responses for diagnosis of Helicobacter pylori infection in children. J Clin Microbiol 2001;39:3591-96.
- Koletzko S, Feydt-Schmidt A. Infants differ from teenagers: use of non-invasive tests for detection of Helicobacter pylori infection in children. Eur J Gastroenterol Hepatol 2001;13:1047-52.
- Кашников В.С., Чуков С.З., Семин С.Г. Неинвазивная диагностика Н. pylori - ассоциированных заболеваний в педиатрической практике. Материалы ХII Конгресса детских гастроэнтерологов России. М., 2005. С. 261-262.
- Trevisani L, Sartori S, Galvani F, et al. Evalution of a new enzyme immunoassay for detecting Helicobacter pylori in feces: a prospective pilot study. Am J Gastroenterol 1999;94:1830-33.
- Vaira D, Malfertheiner P, Megraud F, et al. Diagnosis of Helicobacter pylori with a new non-invasive antigen-based assay. Lancet 1999;354:30-33.
- Braden B, Posselt P, Ahrens P, et al. New immunoassay in stool provides an accurate noninvasive diagnostic method for Helicobacter pylori screening in children. Pediatrics 2000;106:115-17.
- Oderda G, Rappa A, Ronchi B, et al. Detection of Helicobacter pylori in stool specimens by noninvasive antigen enzyme immunoassay in children: multicentre Italian study. BMJ 2000;320:347-48.
- Konstantopoulos N, Russmann H, Tasch C, et al. Evalution of the Helicobacter pylori stool antigen test (HpSA) for detection of Helicobacter pylori infection in children. Am J Gastroenterolog 2001;96:677-83.
- Oderda G, Rappa A, Marinello D, et al. Usefulness of Helicobacter pylori stool antigen test to monitor response to eradication treatment in children. Aliment Pharmacol Ther 2001;15:203-06.
- Megraud F. Non-invasive tests to detect Helicobacter pylori infection in children and adolescents: results of multicentric European study. J Pediatr 2005;146:198-203.
- Koletzko S, Konstantopoulos N, Bosman D, et al. Evalution of a novel monoclonal enzyme immunoassay for detection of Helicobacter pylori antigen in stool from children. Gut 2003;52:804-06.